Looking to publish in Hepatology International? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginHepatology International is a peer-reviewed journal dedicated to research and patient care issues in hepatology. It focuses on contemporary clinical and basic science related issues in adult and pediatric hepatobiliary and allied sciences, and publishes original research articles, editorials, reviews, and consensus guidelines for diagnosis and treatment of liver diseases. The journal emphasizes new and emerging technologies, innovations, and future trends in liver and biliary disorders.
Looking to publish in Hepatology International? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginSubmission Instructions
Hepatology International is an invitation-only journal. Submissions are accepted by invitation from the editorial board only. The following article types are accepted:
Original Article
Review Article
Mini Review
Consensus
Letter To Editor
Recent Publications
Clinical and pathological significance of serum anti-PD-1 autoantibodies in acute-onset and chronic autoimmune hepatitis
Takashi Oda, Akinobu Takaki, Kenichi Harada, Teruko Arinaga-Hino, Masanori Abe, Takeshi Matsui, Atsushi Takahashi, Hiromasa Ohira, Yoshiyuki Suzuki, Nobuhiro Nakamoto, Atsushi Tanaka, Kazuyuki Matsumoto, Jinpeng Li, Nozomi Miyake, Masahiko Sue, Takuya Adachi, Yasuto Takeuchi, Hideki Onishi, Miwa Kawanaka, Motoyuki Otsuka
Circulating fibronectin levels are linked to liver function, matrix remodeling, and hemostatic complications in advanced chronic liver disease
Georg Kramer, Irina Andreea Lie-Ungurean, Benedikt Silvester Hofer, Lukas Hartl, Mathias Jachs, Lorenz Balcar, Georg Semmler, Christian Sebesta, Paul Thöne, Marlene Hintersteininger, Paula Höfinger, Rodrig Marculescu, Thomas Perkmann, Philipp Schwabl, Michael Trauner, Mattias Mandorfer, Thomas Reiberger, Benedikt Simbrunner
The Global ACLF Consensus : the ‘Istanbul Document’
Anand V. Kulkarni, Ashok Choudhury, Vinod Arora, Abdul Kadir Dokmeci, Abraham Koshy, Ahmet Gurakar, Ajay Duseja, Akash Roy, Akash Shukla, Aleksander Krag, Alfred Wei Chieh Kow, Ananta Shrestha, Apichat Kaewdech, Ashish Goel, Ashish Kumar, Ashwani K. Singal, Aung Hlaing Bwa, Chanunta Hongthanakorn, Cosmas Rinaldi Adithya Lesmana, Daniel Huang, Darrell Crawford, Debbie Shawcross, Deniz Balchi, Dhiraj Agrawal, Diana A. Payawal, Do Seon Song, Dong Joon Kim, Fernando Bessone, George K. Lau, Giacomo Germani, Girish Kumar Pati, Grace L. Su, Guan-Huei Lee, Gupse Adali, Gyongyi Szabo, Hasmik Ghazinian, Jacob George, James Fung, Jasmohan Bajaj, P. Javed, Jidong Jia, Jimmy Che-To Lai, Jin Jun Chen, Jonel Trebicka, Jun Li, Kavish Patidar, Kemal Fariz Kalista, Ken Liu, Kessarin Thanapirom, Lai Wei, M. Golam Azam, Madhumita Premkumar, Madunil Niriella, Manasa Alla, Mangesh Pagadala, Manoj Kumar, Manuel Mendizabal, Mario Guimaraes Pessoa, Mark Dhinesh Muthiah, Masao Omata, Mazen Noureddin, Md. Fazal Karim, Mithun Sharma, Mohamed Alboraie, Mohamed Elbasiony, Murat Harputluoglu, Narendra Singh Choudhary, Nazia Selzner, Necati Ormeci, Nelia Hernandez, Nipun Verma, Paolo Angeli, Phunchai Charatcharoenwitthaya, Prabir Maji, Pravin Rathi, R. K. Dhiman, Rahul Kumar, Rakhi Maiwall, Ramazan Idilman, Richard Moreau, Rino A. Gani, Rosmawati Mohamed, S. S. Hamid, Sanjeev Sachdeva, Senamjit Kaur, Shahinul Alam, Soe Thiha Maung, Soek-Siam Tan, T. R. Sowmya, K. C. Sudhamshu, Sumana Ramachandra, Sunil Kumar Dadhich, Sunil Taneja, Suprabhat Giri, Surender Singh, Tao Chen, Tarana Gupta, Tushar Madke, V. M. Dayal, Venishetty Shantan, Viniyendra Pamecha, Wong Yu Jun, Xiaolong Qi, Yoon Jun Kim, Zaigham Abbas, Zobair M. Younossi, Shiv Kumar Sarin
Dynamic changes in controlled attenuation parameter (CAP) improve prognostic prediction for CHB patients with significant fibrosis and cirrhosis
Xiaowei Ai, Mengyang Zhang, Shuyan Chen, Xinyu Zhao, Jialing Zhou, Tongtong Meng, Bingqiong Wang, Chenglin Sun, Xiao Han, Yankun Gao, Xiaoning Wu, Hong You, Yameng Sun
How to apply artificial intelligence (AI) to facilitate and enhance MASH trials
Daniel Yan Zheng Lim, Wei Qiang Leow, Daniela S. Allende, Wai Kay Seto, Terry Cheuk-Fung Yip, George Boon Bee Goh
Frequently asked questions
How long does it take to publish?
Articles are published online after receipt of the corrected proofs.
Reformat to Hepatology International using Livewrite PremiumIs a cover letter required?
A submission letter is used when suggesting reviewers and when disclosing unpublished material included in the manuscript.
Reformat to Hepatology International using Livewrite PremiumWhat are the publication costs?
Open access APC: £3290.00 GBP / $5290.00 USD / €4090.00 EUR, subject to VAT or local taxes where applicable. Subscription publishing has no APC charges.
Reformat to Hepatology International using Livewrite Premium